VJX-18734-01051
3 vaccinations
4 coded responses
30 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 019 / MA
- Registered
- 2021-02-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
NMM-20844-86986
Child or adolescent in my care · Male · 2021-11-09
Timeline
-
2021-02-07
Dose 1 — Pfizer-BioNTech
-
2021-02-28
Registered in v-safe
- 2021-02-28
-
2021-03-01
Dose 2 — Pfizer-BioNTech
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Hordeolum — Feeling: GoodFree text: I started getting a stye on my eye Tuesday, March 2nd.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-16
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-06-01
- 2021-08-30
-
2021-12-08
Dose 3 — Pfizer-BioNTech
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Nasal congestion — Feeling: Good · Site: Pain, Swelling, Itching · HeadacheFree text: Had some nasal congestion that mostly resolvedMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-15
- 2021-12-24
- 2021-12-29
- 2022-01-05
- 2022-01-12
-
2022-03-09
Survey response — 3 months, dose 3MedDRA: Tendonitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: flexor tendinitisMedDRA releases: 2024-11 · check-in free text available
-
2022-03-09
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-11
- 2022-06-10
- 2022-12-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-07 | Pfizer-BioNTech | |
| 2 | 2021-03-01 | Pfizer-BioNTech | |
| 3 | 2021-12-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-09 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): I started getting a stye on my eye Tuesday, March 2nd.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Had some nasal congestion that mostly resolved
Systemic reaction (other): runny nose
Release 11 — 3 months, dose 3
Symptoms: flexor tendinitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Tendonitis | · | · | ✓ |
| SRO | Hordeolum | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release